What Does a Multi-Dose Series Mean for the COVID-19 Vaccination Effort?
This issue brief examines key issues related to multi-dose vaccination series generally as well as issues specific to COVID-19.
View the Latest: Vaccines
Filter
-
-
Data as of February 1 on State Vaccinations by Race/Ethnicity
News ReleaseUpdated analysis of state-reported data as of February 1, 2021 on COVID-19 vaccinations, cases, and deaths by race/ethnicity is now available.
-
Vaccine Monitor: Where People are Getting Information About COVID-19 Vaccinations
News ReleaseAdditional Data Available Through Online Vaccine Monitor Dashboard As vaccination efforts ramp up across the country, the KFF COVID-19 Vaccine Monitor examines where the public is getting its relevant information.
-
This Week in Coronavirus: January 22 to January 28
Policy WatchDuring the 53rd week since the first coronavirus case appeared in the United States, the world surpassed 100 million COVID-19 cases, with the United States accounting for a quarter of them. The U.S. also accounts for one-fifth (433,200) of the world’s nearly 2.2 million reported deaths.
-
Vaccine Monitor: Nearly Half of the Public Wants to Get a COVID-19 Vaccine as Soon as They Can or Has Already Been Vaccinated, Up across Racial and Ethnic Groups Since December
News ReleaseMost Convincing Messages to Promote Vaccination Highlight Effectiveness at Preventing Illness and a Return to Normal Life; Hearing about Rare Allergic Reactions and Side Effects May Discourage Some New KFF Dashboard Features Key Data and Insights from the Vaccine Monitor With millions of Americans getting their first COVID-19 vaccinations, the public’s eagerness to get a…
-
Racial Diversity within COVID-19 Vaccine Clinical Trials: Key Questions and Answers
Issue BriefThis brief reviews why racial diversity within COVID-19 vaccine clinical trials is important, discusses the barriers to participation in clinical trials among people of color, and examines the racial/ethnic composition of clinical trial participants for the Pfizer-BioNTech and Moderna vaccines.
-
How Quickly We Need To Ramp Up Vaccinations To Get To Herd Immunity
From Drew AltmanDebate about how many vaccinations are needed by when has been in the news. Drew Altman lays it out in his latest column.
-
This Week in Coronavirus: January 15 to January 21
Policy WatchDuring the 52nd week since the first coronavirus case appeared in the United States, the U.S. surpassed 24.6 million total cases and 410,100 deaths due to the pandemic. Here’s our recap of the past week in the coronavirus pandemic from our tracking, policy analysis, polling, and journalism.
-
New Resources Track State Vaccinations by Race/Ethnicity and Examine Demographics of Health Workers
News ReleaseA new Policy Watch, Early State Vaccination Data Raise Warning Flags for Racial Equity, explores the latest state-reported data on vaccination by race/ethnicity available on KFF’s COVID-19 state data and policy tracker.
-
Nearly 6 in 10 Older Americans Don’t Know When or Where They Can Get a COVID-19 Vaccine; Black and Hispanic Adults among the Groups Least Likely to Have Enough Information
News ReleaseDespite Optimism about COVID-19 Vaccines in the Future, Half Say They are Frustrated with the Current Situation and Nearly a Quarter are Angry While older Americans are a high-priority group for getting a COVID-19 vaccine, the latest KFF COVID-19 Vaccine Monitor report finds that, among those who have not yet been vaccinated, most people ages 65 and…